<DOC>
	<DOCNO>NCT01070511</DOCNO>
	<brief_summary>Summary Patients : This study , fund Muscular Dystrophy Association , intend build recent finding publish journal Nature show beneficial effect tadalafil ( also know Cialis ) mouse animal version Duchenne Becker muscular dystrophy . Only two dos tadalafil improved muscle blood flow , allow dystrophic mouse perform exercise le muscle injury . This new short-term clinical trial move test animal human patient Becker muscular dystrophy examine effect acute tadalafil dose muscle blood flow bout exercise . Patients take two dos tadalafil prior exercise . Then doctor measure whether muscle receive increase blood flow therefore well protect exercise . Scientific Hypothesis : In patient Becker muscular dystrophy ( particularly dystrophin gene mutation exon 41-46 ) , loss sarcolemmal nitric oxide synthase engenders functional muscle ischemia thus muscle edema acute bout exercise . The investigator hypothesize PDE5A inhibition , boost nitric oxide-cGMP signaling , constitutes effective new countermeasure patient .</brief_summary>
	<brief_title>Tadalafil Becker Muscular Dystrophy</brief_title>
	<detailed_description>There 2 phase research project : ( 1 ) initial baseline study compare patient Becker muscular dystrophy healthy control subject , ( 2 ) subsequent brief treatment trial muscular dystrophy patient ( healthy control participate second phase study ) . The baseline study involve intake history , physical examination , phlebotomy blood chemistry DNA follow ( ) MRI scan forearm muscle brief bout handgrip exercise approximately 1-1.5 hour complete ) , ( b ) non-invasive forearm blood flow study ( Near Infrared Spectroscopy , Doppler Ultrasound ) brief bout handgrip exercise ( approximately 3-5 hour complete ) . Blood flow study perform subject 's low body enclose airtight chamber . Blood flow oxygen delivery forearm muscle measure application lower body negative pressure rest handgrip exercise . Lower body negative pressure simulate blood flow change normally occur person sits lie . The result baseline study determine patient meet preset eligibility criterion participate medication phase study . These criterion include ( 1 ) normal kidney liver function test normal BNP level ( latter exclude heart failure ) , ( 2 ) abnormal MRI blood flow response handgrip exercise . Eligible patient ask repeat laboratory procedure two study day : one day receive 2 pill tadalafil ( PDE5A inhibitor longer-lasting Viagra ) another day receive 2 placebo pill . Study procedures break two separate day schedule purpose and/or avoid fatigue . Patients complete trial receive study medication order random . In summary , healthy control subject undergo baseline study whereas Becker muscular dystrophy patient complete phase project 3 separate study day ( baseline , tadalafil , placebo ) 2 medication visit ( receive study medication blood pressure check study physician ) . Study day separate least two week allow time test result , rest forearm muscle exercise bout , ensure complete elimination tadalafil . We plan enroll 24 adult men Becker muscular dystrophy , 12 men dystrophin gene deletion exon 41-46 , 24 healthy control subject .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Becker Muscular Dystrophy Patients Men 1855 year age preexist diagnosis Becker Muscular Dystrophy clinical neurologist ( base clinical criterion plus previous muscle biopsy analysis and/or DNA analysis ) . Healthy Controls Men 1855 year age know medical condition Criteria exclusion subject ( patient control ) Any evidence cardiopulmonary disease history physical examination History hypertension blood pressure average ≥140/90 mmHg Diabetes mellitus systemic illness Heart failure clinical exam , elevate BNP , heart failure medication Serum creatinine ≥ 1.5 mg/dL Any history substance abuse ( include alcohol ) Any history psychiatric illness Contraindications tadalafil ( use nitrate , alphablockers , PDE5A inhibitor , potent inhibitor CYP3A4 ketoconazole ritonavir ) Contraindications MRI ( claustrophobia , metal implant , seizure disorder )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Muscular Dystrophy</keyword>
	<keyword>Tadalafil</keyword>
</DOC>